Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders Clinic

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Study Classification

OBSERVATIONAL

Study Start Date

2004-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Main Research questions:

1. Who are the patients referred for treatment at the Psychotic Disorders Clinic?
2. What are the outcomes from treatment for first episode psychosis in multiple outcome domains?
3. What hospital resources are used over the early course of the illness?
4. How satisfied are patients and family with the treatment and services they received? This is an important study that will help us evaluate the service and treatment offered by the Psychotic Disorders Clinic's specialized early intervention program,which helps young people experiencing early stages of psychotic illness.A growing body of evidence suggests that intervening earlier in the course of the illness with specialized and complimentary pharmacological and psychosocial treatment may be associated with improved outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The project is primarily a descriptive study of individuals experiencing their first episode of psychosis presenting at the Psychotic Disorders Clinic/Early Intervention Program.

The objectives of the study are:

1. Track multi-dimensional outcomes within the program
2. Track service use
3. Compare outcomes for this early intervention program with outcomes noted in published follow up studies
4. Evaluate effectiveness of the Psychotic Disorders Clinic in improving outcomes for persons experiencing their first episode of psychosis

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophreniform,First Episode Psychosis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

early intervention,program evaluation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

DEFINED_POPULATION

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male or female between ages of 16 to 50 years of age
* capable of providing informed consent
* receiving treatment voluntarily
* experiencing a "first episode of psychosis" defined as the first episode of illness and where the subject,at presentation,meets DSM-IV criteria for one of the following diagnoses:schizophrenia,schizophreniform disorder,schizoaffective disorder,brief psychotic disorder,delusional disorder,and psychosis NOS

Exclusion Criteria

* primary diagnosis of mood disorder
* diagnosis of substance-induced psychosis
* diagnosis of psychosis due to a general medical condition
* diagnosis of mental retardation
* diagnosis of developmental disorder
* has received antipsychotic treatment for greater than 1 month
* has received treatment for an earlier episode of psychosis from which there has been a remission of symptoms for greater than 3 months

Minimum Eligible Age

16 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Suzanne Archie, MD,FRCP(C)

Role: PRINCIPAL_INVESTIGATOR

Assistant Professor Dept of Psychiatry and Behavioural Neurosciences McMaster University.Active Medical Staff Hamilton Health Sciences.Clinical Director of Cleghorn Early Intervention in Psychosis Program and Psychotic Disorders Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cleghorn Program-Early Intervention in Psychosis.St Joseph's Healthcare Hamilton/Hamilton Health Sciences

Hamilton, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REB #04-203

Identifier Type: -

Identifier Source: org_study_id